Ceva launches Vectormune® HVT-NDV

Ceva enjoyed prominent positioning at VIV Asia 2011 while its team of experts at the show were kept on their toes with dedicated symposiums and meetings for both the poultry and swine sectors.

Ceva enjoyed prominent positioning at VIV Asia 2011 while its team of experts at the show were kept on their toes with dedicated symposiums and meetings for both the poultry and swine sectors.

The Company used VIV as a platform to launch its latest vector poultry vaccine Vectormune® HVT-NDV, which protects against both Newcastle and Marek's diseases.

A special symposium on Newcastle disease was staged and this attracted over 200 poultry specialists.

A similar well attended symposium was held for the swine sector.

Back to top